Re-evaluating the predictive roles of metabolic complications and clinical outcome according to eGFR levels - A four-years prospective cohort study in Taiwan

BMC Nephrology

Volumn 14, Issue 1, 2013, Pages

  Wu, I Wen ^a,b   Hsu, Kuang Hung ^c   Lee, Chin Chan ^a,b   Sun, Chiao Yin ^a,b   Hsu, Heng Jung ^a,b   Hung, Ming Jui ^a,b   Wu, Mai Szu ^a,d,e  

^a CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^b School of Medicine   (Taiwan)

^c CHANG GUNG UNIVERSITY   (Taiwan)

^d TAIPEI MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^e TAIPEI MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Anemia; Chronic kidney disease; Death; Hyperphosphatemia; Hypoalbuminemia; Metabolic complications; Renal progression

Indexed keywords

ACIDOSIS; ADULT; AGED; ANEMIA; ARTICLE; CAUSE OF DEATH; CHRONIC KIDNEY DISEASE; COHORT ANALYSIS; DEATH; DIALYSIS; DISEASE ASSOCIATION; DISEASE COURSE; FEMALE; FOLLOW UP; GLOMERULUS FILTRATION RATE; HUMAN; HYPERKALEMIA; HYPERPARATHYROIDISM; HYPERPHOSPHATEMIA; HYPERURICEMIA; HYPOALBUMINEMIA; INFLAMMATION; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; METABOLIC DISORDER; OUTCOME ASSESSMENT; PREDICTIVE VALUE; PREVALENCE; PROSPECTIVE STUDY; TAIWAN;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; COHORT STUDIES; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; MALE; METABOLIC DISEASES; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; RENAL INSUFFICIENCY, CHRONIC; TAIWAN; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84876728739     PISSN: None     EISSN: 14712369     Source Type: Journal    
DOI: 10.1186/1471-2369-14-92     Document Type: Article

References (26)

1. Prognosis of CKD patients receiving outpatient nephrology care in Italy. De Nicola L, Chiodini P, Zoccali C, Borrelli S, Cianciaruso B, Di Iorio B, Santoro D, Giancaspro V, Abaterusso C, Gallo C, Clin J Am Soc Nephrol 2011 6 10 2421 2428 10.2215/CJN.01180211 21817127
2. Factors associated with kidney disease progression and mortality in a referred CKD population. Hoefield RA, Kalra PA, Baker P, Lane B, New JP, O'Donoghue DJ, Foley RN, Middleton RJ, Am J Kidney Dis 2010 56 6 1072 1081 10.1053/j.ajkd.2010.06.010 20692750
3. The definition, classification, and prognosis of chronic kidney disease: a KDIGO controversies conference report. Levey AS, de Jong PE, Coresh J, El Nahas M, Astor BC, Matsushita K, Gansevoort RT, Kasiske BL, Eckardt KU, Kidney Int 2011 80 1 17 28 10.1038/ki.2010.483 21150873
4. Prevalence and prognosis of mild anemia in non-dialysis chronic kidney disease: a prospective cohort study in outpatient renal clinics. De Nicola L, Minutolo R, Chiodini P, Zamboli P, Cianciaruso B, Nappi F, Signoriello S, Conte G, Zoccali C, Group S-TCS, Am J Nephrol 2010 32 6 533 540 10.1159/000321468 20980739
5. Chronic kidney disease progression and outcome according to serum phosphorus in mild-to-moderate kidney dysfunction. Bellasi A, Mandreoli M, Baldrati L, Corradini M, Di Nicolo P, Malmusi G, Santoro A, Clin J Am Soc Nephrol 2011 6 4 883 891 10.2215/CJN.07810910 21393493
6. The frequency of hyperkalemia and its significance in chronic kidney disease. Einhorn LM, Zhan M, Hsu VD, Walker LD, Moen MF, Seliger SL, Weir MR, Fink JC, Arch Intern Med 2009 169 12 1156 1162 10.1001/archinternmed.2009.132 19546417
7. Serum bicarbonate and long-term outcomes in CKD. Menon V, Tighiouart H, Vaughn NS, Beck GJ, Kusek JW, Collins AJ, Greene T, Sarnak MJ, Am J Kidney Dis 2010 56 5 907 914 10.1053/j.ajkd.2010.03.023 20605301
8. Association of uric acid with change in kidney function in healthy normotensive individuals. Bellomo G, Venanzi S, Verdura C, Saronio P, Esposito A, Timio M, Am J Kidney Dis 2010 56 2 264 272 10.1053/j.ajkd.2010.01.019 20385436
9. Inflammation, hemostasis, and the risk of kidney function decline in the atherosclerosis risk in communities (ARIC) study. Bash LD, Erlinger TP, Coresh J, Marsh-Manzi J, Folsom AR, Astor BC, Am J Kidney Dis 2009 53 4 596 605 10.1053/j.ajkd.2008.10.044 19110358
10. Multidisciplinary predialysis education decreases the incidence of dialysis and reduces mortality-a controlled cohort study based on the NKF/DOQI guidelines. Wu IW, Wang SY, Hsu KH, Lee CC, Sun CY, Tsai CJ, Wu MS, Nephrol Dial Transplant 2009 24 3426 3433 10.1093/ndt/gfp259 19491379
11. Clinical practice guidelines and clinical practice recommendations for anemia in chronic kidney disease. KDOQI, Am J Kidney Dis 2006 47 5 Suppl 3 11 S145 16678659
12. Clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of chronic kidney disease-mineral and bone disorder (CKD-MBD). KDIGO, Kidney Int Suppl 2009 113 1 S130
13. A note on a general definition of the coefficient of determination. Nagelkerke NJD, Biometrika 1991 78 691 692 10.1093/biomet/78.3.691
14. C-reactive protein and albumin as predictors of all-cause and cardiovascular mortality in chronic kidney disease. Menon V, Greene T, Wang X, Pereira AA, Marcovina SM, Beck GJ, Kusek JW, Collins AJ, Levey AS, Sarnak MJ, Kidney Int 2005 68 2 766 772 16014054 (Pubitemid 43323132)
15. Clinical practice guidelines for nutrition in chronic renal failure. K/DOQI, National Kidney Foundation, Am J Kidney Dis 2000 35 6 Suppl 2 1 S140 10895784
16. The prevalence of hematologic and metabolic abnormalities during chronic kidney disease stages in different ethnic groups. Barbour SJ, Er L, Djurdjev O, Karim MA, Levin A, Kidney Int 2008 74 1 108 114 10.1038/ki.2008.151 18432185 (Pubitemid 351841895)
17. Timing of onset of CKD-related metabolic complications. Moranne O, Froissart M, Rossert J, Gauci C, Boffa JJ, Haymann JP, M'Rad MB, Jacquot C, Houillier P, Stengel B, J Am Soc Nephrol 2009 20 1 164 171 10.1681/ASN. 2008020159 19005010
18. Estimated GFR, albuminuria, and complications of chronic kidney disease. Inker LA, Coresh J, Levey AS, Tonelli M, Muntner P, J Am Soc Nephrol 2011 22 12 2322 2331 10.1681/ASN.2010111181 21965377
19. The MYH9/APOL1 region and chronic kidney disease in european-americans. O'Seaghdha CM, Parekh RS, Hwang SJ, Li M, Kottgen A, Coresh J, Yang Q, Fox CS, Kao WH, Hum Mol Genet 2011 20 12 2450 2456 10.1093/hmg/ddr118 21429915
20. Screening for chronic kidney disease complications in US adults: racial implications of a single GFR threshold. Ibrahim HN, Wang C, Ishani A, Collins AJ, Foley RN, Clin J Am Soc Nephrol 2008 3 6 1792 1799 10.2215/CJN.01890408 18784208
21. Differences in progression of CKD and mortality amongst caucasian, oriental asian and south asian CKD patients. Barbour SJ, Er L, Djurdjev O, Karim M, Levin A, Nephrol Dial Transplant 2010 25 11 3663 3672 10.1093/ndt/gfq189 20368302
22. Outcomes associated with phosphorus binders in men with non-dialysis-dependent CKD. Kovesdy CP, Kuchmak O, Lu JL, Kalantar-Zadeh K, Am J Kidney Dis 2010 56 5 842 851 10.1053/j.ajkd.2010.06.011 20728255
23. Optimal vitamin D, calcitriol, and vitamin D analog replacement in chronic kidney disease: to D or not to D: that is the question. Moorthi RN, Kandula P, Moe SM, Curr Opin Nephrol Hypertens 2011 20 4 354 359 10.1097/MNH.0b013e3283470450 21654391
24. Hemoglobin variability in nondialysis chronic kidney disease: examining the association with mortality. Boudville NC, Djurdjev O, Macdougall IC, de Francisco AL, Deray G, Besarab A, Stevens PE, Walker RG, Urena P, Inigo P, Clin J Am Soc Nephrol 2009 4 7 1176 1182 10.2215/CJN.04920908 19423567
25. Treatment of chronic kidney disease. Turner JM, Bauer C, Abramowitz MK, Melamed ML, Hostetter TH, Kidney Int 2012 81 4 351 362 10.1038/ki.2011.380 22166846
26. Measured GFR does not outperform estimated GFR in predicting CKD-related complications. Hsu CY, Propert K, Xie D, Hamm L, He J, Miller E, Ojo A, Shlipak M, Teal V, Townsend R, J Am Soc Nephrol 2011 22 10 1931 1937 10.1681/ASN.2010101077 21921144